CAP1 Antikörper (AA 266-462)
Kurzübersicht für CAP1 Antikörper (AA 266-462) (ABIN1886289)
Target
Alle CAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 266-462
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 266 and 462 of CAP1
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))
-
Andere Bezeichnung
- CAP1
-
Hintergrund
-
The protein encoded by this gene is related to the S.cerevisiae CAP protein, which is involved in the cyclic AMP pathway.The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin.Alternatively spliced transcript variants have been identified.[provided by RefSeq]
-
Molekulargewicht
- 52 kDa
-
Gen-ID
- 10487
-
NCBI Accession
- NM_001105530, NP_001099000
-
Pathways
- cAMP Metabolic Process
Target
-